Creative Planning’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,466
Closed -$471K 3219
2024
Q1
$471K Buy
13,466
+196
+1% +$7.15K ﹤0.01% 1897
2023
Q4
$504K Buy
13,270
+1,090
+9% +$23.4K ﹤0.01% 1708
2023
Q3
$224K Buy
12,180
+180
+2% +$3.77K ﹤0.01% 2158
2023
Q2
$312K Hold
12,000
﹤0.01% 1885
2023
Q1
$226K Sell
12,000
-278
-2% -$6.46K ﹤0.01% 2029
2022
Q4
$303K Buy
12,278
+278
+2% +$8.17K ﹤0.01% 1724
2022
Q3
$215K Hold
12,000
﹤0.01% 1866
2022
Q2
$136K Hold
12,000
﹤0.01% 1933
2022
Q1
$267K Hold
12,000
﹤0.01% 1710
2021
Q4
$524K Hold
12,000
﹤0.01% 1275
2021
Q3
$400K Hold
12,000
﹤0.01% 1424
2021
Q2
$330K Hold
12,000
﹤0.01% 1515
2021
Q1
$241K Buy
+12,000
New +$350K ﹤0.01% 1951

Other funds holding INBX

Creative Planning's INBX Position: Q2 2024 in Review

Creative Planning sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 13,466 shares — an estimated $471K sold.

Creative Planning first reported a position in INBX in Q1 2021 and held it in 13 quarters. The position peaked at $524K in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Creative Planning reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Creative Planning sold 13,466 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $471K.
  • Creative Planning first reported a position in Inhibrx, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Creative Planning's Inhibrx, Inc. Common Stock position peaked at $524K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Creative Planning's 13F filing for Q2 2024, filed 15 Aug 2024.